Publication | Open Access

Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer

Breast OncologyMedicineStandard Neoadjuvant ChemotherapyBreast CancerCancer TreatmentOncologyRadiation OncologyMolecular Oncology